Classification
It is possible to classify autoimmune diseases by corresponding type of hypersensitivity: type II, type III, or type IV. (No type of autoimmune disease mimics type I hypersensitivity.)
There is continuing debate about when a disease should be considered autoimmune, leading to different criteria such as Witebsky's postulates.
- This is an incomplete list, which may never be able to satisfy particular standards for completeness. You can help by expanding it with reliably sourced entries.
| Name: | Accepted/ suspected |
Hypersensitivity
I, II, III, IV |
Autoantibody | Notes | |
|---|---|---|---|---|---|
| Acute disseminated encephalomyelitis (ADEM) | Accepted | ||||
| Addison's disease | interferon omega; transglutaminase; aromatic acid carboxylase; GAD; HAI; 17 hydroxylase; 21 hydroxylase | ||||
| Agammaglobulinemia | IGHM; IGLL1: CD79A; CD79B; BLNK; LRRC8A | ||||
| Alopecia areata | Accepted | T-cells | |||
| Amyotrophic Lateral Sclerosis | |||||
| Ankylosing Spondylitis | Suspected | CD8; HLA-B27 | |||
| Antiphospholipid syndrome | Accepted | anti-cardiolipin;anti pyruvate dehydrogenase; β2 glycoprotein I; phosphatidylserine; anti apoH; Annexin A5 | HLA-DR7, HLA-B8, HLA-DR2, HLA-DR3 | ||
| Antisynthetase syndrome | |||||
| Atopic allergy | I | ||||
| Atopic dermatitis | I | ||||
| Autoimmune aplastic anemia | |||||
| Autoimmune cardiomyopathy | Accepted | ||||
| Autoimmune enteropathy | |||||
| Autoimmune hemolytic anemia | Accepted | II | complement activation | ||
| Autoimmune hepatitis | Accepted | cell-mediated | anti-mitochondrial antibodies; ANA; anti-smooth muscle antibodies, LKM-1; soluble liver antigen | ||
| Autoimmune inner ear disease | Accepted | ||||
| Autoimmune lymphoproliferative syndrome | Accepted | TNFRSF6; defective Fas-CD95 apoptosis | |||
| Autoimmune peripheral neuropathy | Accepted | ||||
| Autoimmune pancreatitis | Accepted | ANA; anti-lactoferrin antibodiesanti-carbonic anhydrase antibodies; rheumatoid factor | |||
| Autoimmune polyendocrine syndrome | Accepted | Unknown or multiple | APS-1 see Addison's disease | ||
| Autoimmune progesterone dermatitis | Accepted | ||||
| Autoimmune thrombocytopenic purpura | Accepted | anti gpIIb-IIIa or 1b-IX | |||
| Autoimmune urticaria | Accepted | ||||
| Autoimmune uveitis | Accepted | HLAB-27? | |||
| Balo disease/Balo concentric sclerosis | |||||
| Behçet's disease | Accepted | immune-mediated systemic vasculitis; linkage to HLA-B51 (HLA-B27); very different manifestations with ulcers as common symptom; also called Morbus Adamandiades-Behçet | |||
| Berger's disease | IgA (elevated in 50% of patients), IgA (in mesangial deposits on kidney biopsy) | ||||
| Bickerstaff's encephalitis | Anti-GQ1b 2/3 patients | similar to Guillain-Barré syndrome | |||
| Blau syndrome | overlaps both sarcoidosis and granuloma annulare | ||||
| Bullous pemphigoid | IgG autoantibodies targeting the type XVII collagen component of hemidesmosomes | ||||
| Cancer | |||||
| Castleman's disease | Over expression of IL-6 | ||||
| Celiac disease | Accepted | IV?? | Anti-tissue transglutaminase antibodies anti-endomysial IgA, anti-gliadin IgA | HLA-DQ8 and DQ2.5 | |
| Chagas disease | Suspected | ||||
| Chronic inflammatory demyelinating polyneuropathy | Anti-ganglioside antibodies:anti-GM1, anti-GD1a, anti-GQ1b | similar to Guillain-Barré syndrome | |||
| Chronic recurrent multifocal osteomyelitis | LPIN2, D18S60,similar to Majeed syndrome | ||||
| Chronic obstructive pulmonary disease | Suspected | ||||
| Churg-Strauss syndrome | p-ANCA | ||||
| Cicatricial pemphigoid | anti-BP-1, anti BP-2 | precipitates C3 | |||
| Cogan syndrome | |||||
| Cold agglutinin disease | Accepted | II | IgM | idiopathic or secondary to leukemia or infection | |
| Complement component 2 deficiency | |||||
| Contact dermatitis | IV | ||||
| Cranial arteritis | aka Temporal arteritis; involves giant cells | ||||
| CREST syndrome | Anti-centromere antibodies Anti-nuclear antibodies | ||||
| Crohn's disease (one of two types of idiopathic inflammatory bowel disease "IBD") | Accepted | IV | Innate immunity; Th17; Th1; ATG16L1; CARD15;XBP1; | ||
| Cushing's Syndrome | cortisol binding globulin? | ||||
| Cutaneous leukocytoclastic angiitis | neutrophils | ||||
| Dego's disease | Vasculopathy | ||||
| Dercum's disease | Suspected | Lipoid tissue. | |||
| Dermatitis herpetiformis | IgA; anti-epidermal transglutaminase antibodies | ||||
| Dermatomyositis | Accepted | histidine-tRNA anti-signal recognition peptide Anti-Mi-2 Anti-Jo1. | B- and T-cell perivascular inflammatory infiltrate on muscle biopsy | ||
| Diabetes mellitus type 1 | Accepted | IV | Glutamic acid decarboxylase antibodies (GADA), islet cell antibodies (ICA), and insulinoma-associated autoantibodies (IA-2), anti-insulin antibodies | HLA-DR3, HLA-DR4 | |
| Diffuse cutaneous systemic sclerosis | anti-nuclear antibodies, anti-centromere and anti-scl70/anti-topoisomerase antibodies | COL1A2 and TGF-β1 | |||
| Dressler's syndrome | myocardial neo-antigens formed as a result of the MI | ||||
| Drug-induced lupus | anti-histone | ||||
| Discoid lupus erythematosus | III | IL-2 and IFN-gamma> | |||
| Eczema | LEKTI, SPINK5, filaggrin., Brain-derived neurotrophic factor (BDNF) and Substance P. | ||||
| Endometriosis | Suspected | ||||
| Enthesitis-related arthritis | . | MMP3 TRLR2, TLR4, ERAP1 | |||
| Eosinophilic fasciitis | Accepted | ||||
| Eosinophilic gastroenteritis | IgE | IL-3, IL-5, GM-CSF, eotaxin | |||
| Epidermolysis bullosa acquisita | COL7A1 | ||||
| Erythema nodosum | |||||
| Erythroblastosis fetalis | II | ABO, Rh, Kell antibodies | mother's immune system attacks fetus | ||
| Essential mixed cryoglobulinemia | |||||
| Evan's syndrome | |||||
| Fibrodysplasia ossificans progressiva | ACVR1 Lymphocytes express increased BMP4 | ||||
| Fibrosing alveolitis (or Idiopathic pulmonary fibrosis) | SFTPA1, SFTPA2, TERT, and TERC. | ||||
| Gastritis | serum antiparietal and anti-IF antibodies | ||||
| Gastrointestinal pemphigoid | Accepted | ||||
| Glomerulonephritis | Sometimes | IgA | see Buerger's disease for IgA; Membranous glomerulonephritis for IgG; Membranoproliferative/mesangiocapillary GN (Complement activation); Goodpasture's syndrome; Wegener's granulomatosis | ||
| Goodpasture's syndrome | Accepted | II | Anti-Basement Membrane Collagen Type IV Protein | ||
| Graves' disease | Accepted | II | thyroid autoantibodies (TSHR-Ab) that activate the TSH-receptor (TSHR) | ||
| Guillain-Barré syndrome (GBS) | Accepted | IV | Anti-ganglioside | ||
| Hashimoto's encephalopathy | Accepted | IV | alpha-enolase | ||
| Hashimoto's thyroiditis | Accepted | IV | antibodies against thyroid peroxidase and/or thyroglobulin | HLADR5, CTLA-4 | |
| Henoch-Schonlein purpura | immunoglobulin A (IgA) and complement component 3 (C3) | ||||
| Herpes gestationis aka Gestational Pemphigoid | IgG and C3 misdirected antibodies intended to protect the placenta | ||||
| Hidradenitis suppurativa | Suspected | ||||
| Hughes-Stovin syndrome | |||||
| Hypogammaglobulinemia | IGHM, IGLL1, CD79A, BLNK, LRRC8A, CD79B | ||||
| Idiopathic inflammatory demyelinating diseases | a variant of multiple sclerosis | ||||
| Idiopathic pulmonary fibrosis | SFTPA1, SFTPA2, TERT, and TERC. | ||||
| Idiopathic thrombocytopenic purpura (See Autoimmune thrombocytopenic purpura) | Accepted | II | glycoproteins IIb-IIIa or Ib-IX, immunoglobulin G | ||
| IgA nephropathy | III? | IgA produced from marrow rather than MALT | |||
| Inclusion body myositis | similar to polymyositis but does not respond to steroid therapy-activated T8 cells | ||||
| Chronic inflammatory demyelinating polyneuropathy | anti-ganglioside antibodies | similar to Guillain–Barré syndrome | |||
| Interstitial cystitis | Suspected | Mast cells | |||
| Juvenile idiopathic arthritis aka Juvenile rheumatoid arthritis | inconsistent ANA Rheumatoid factor | ||||
| Kawasaki's disease | Suspected | ITPKC HLA-B51 | |||
| Lambert-Eaton myasthenic syndrome | voltage-gated calcium channels; Q-type calcium channel, synaptogagmin, muscarinic acetylcholine receptor M1 | HLA-DR3-B8 | |||
| Leukocytoclastic vasculitis | |||||
| Lichen planus | |||||
| Lichen sclerosus | |||||
| Linear IgA disease (LAD) | |||||
| Lou Gehrig's disease (Also Amyotrophic lateral sclerosis) | VCP, ATXN2, OPTN, FIG4, TARDBP, ANG, VAPB, FUS, SETX, ALS2, SOD1 | ||||
| Lupoid hepatitis aka Autoimmune hepatitis | ANA and SMA, LKM-1, LKM-2 or LKM-3; antibodies against soluble liver antigen(anti-SLA, anti-LP) no autoantibodies detected (~20%) | ||||
| Lupus erythematosus | Accepted | III | Anti-nuclear antibodies anti-Ro. Also, they are often present in Sjögren's syndrome. | ||
| Majeed syndrome | LPIN2 | ||||
| Ménière's disease | III? | major peripheral myelin protein P0 | |||
| Microscopic polyangiitis | p-ANCA myeloperoxidase | binds to neutrophils causing them to degranulate and damages endothelium | |||
| Miller-Fisher syndrome see Guillain-Barre Syndrome | Accepted | anti-GQ1b | |||
| Mixed connective tissue disease | Accepted | anti-nuclear antibody anti-U1-RNP | HLA-DR4 | ||
| Morphea | Suspected | ||||
| Mucha-Habermann disease aka Pityriasis lichenoides et varioliformis acuta | T-cells | ||||
| Multiple sclerosis | Suspected | IV | Anti-KIR4.1 | HLA-DR2, PECAM-1 Anti-Myelin Basic Protein | |
| Myasthenia gravis | Accepted | II | nicotinic acetylcholine receptor MuSK protein | HA-B8 HLA-DR3 HLA-DR1 | |
| Myositis | see Dermatomyositis and Polymyositis see Inclusion-body-myositis | ||||
| Narcolepsy | Suspected | II? | hypocretin or orexin | HLA-DQB1*0602 | |
| Neuromyelitis optica (also Devic's disease) | II? | NMO-IgG aquaporin 4. | |||
| Neuromyotonia | Suspected | II? | voltage-gated potassium channels. | ||
| Occular cicatricial pemphigoid | II? | BP-1, BP-2 | C3 deposition | ||
| Opsoclonus myoclonus syndrome | Suspected | IV? | Lymphocyte recruitment to CSF | ||
| Ord's thyroiditis | |||||
| Palindromic rheumatism | anti-cyclic citrullinated peptide antibodies (anti-CCP) and antikeratin antibodies (AKA) | ||||
| PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcus) | Suspected | II? | antibodies against streptococcal infection serve as auto-antibodies | ||
| Paraneoplastic cerebellar degeneration | IV? II? | anti-Yo (anti-cdr-2 in purkinje fibers) anti-Hu, anti-Tr, antiglutamate receptor | |||
| Paroxysmal nocturnal hemoglobinuria (PNH) | Sometimes(?) | complement attacks RBCs | |||
| Parry Romberg syndrome | ANA | ||||
| Parsonage-Turner syndrome | |||||
| Pars planitis | |||||
| Pemphigus vulgaris | Accepted | II | Anti-Desmoglein 3 | ||
| Pernicious anaemia | Accepted | II | anti-parietal cell antibody | ||
| Perivenous encephalomyelitis | |||||
| POEMS syndrome | interleukin 1β, interleukin 6 and TNFα. vascular endothelial growth factor (VEGF), given the . | ||||
| Polyarteritis nodosa | |||||
| Polymyalgia rheumatica | |||||
| Polymyositis | Accepted | IFN-gamma, IL-1, TNF-alpha | |||
| Primary biliary cirrhosis | Accepted | Anti-p62, Anti-sp100, Anti-Mitochondrial(M2)Anti-Ro aka SSA. Also, they are often present in Sjögren's syndrome. | |||
| Primary sclerosing cholangitis | HLA-DR52a | overlap with primary biliary cirrhosis? | |||
| Progressive inflammatory neuropathy | Suspected | ||||
| Psoriasis | Accepted | IV? | CD-8 T-cells, HLA-Cw6, IL-12b, IL-23b, TNFalpha, NF-κB | ||
| Psoriatic arthritis | Accepted | IV? | HLA=B27 | ||
| Pyoderma gangrenosum | Can occur in conjunction with other immune-related disorders | ||||
| Pure red cell aplasia | |||||
| Rasmussen's encephalitis | anti-NR2A antibodies | ||||
| Raynaud phenomenon | Suspected | Can occur in conjunction with other immune-related disorders | |||
| Relapsing polychondritis | Accepted | ||||
| Reiter's syndrome | |||||
| Restless leg syndrome | Suspected | May occur in Sjögren's syndrome, celiac disease, and rheumatoid arthritis or in derangements of iron metabolism | |||
| Retroperitoneal fibrosis | |||||
| Rheumatoid arthritis | Accepted | III | Rheumatoid factor (anti-IgGFc), Anti-MCV, ACPAs(Vimentin | HLA-DR4, PTPN22, depleted B cells, TNF alpha, IL-17, (also maybe IL-1, 6, and 15) | |
| Rheumatic fever | Accepted | II | streptococcal M protein cross reacts with human myosin, | ||
| Sarcoidosis | Suspected | IV | BTNL2; HLA-B7-DR15; HLA DR3-DQ2. | ||
| Schizophrenia | Suspected | ||||
| Schmidt syndrome another form of APS | anti-21 hydroxylase, anti-17 hydroxylase | DQ2, DQ8 and DRB1*0404 | |||
| Schnitzler syndrome | IgM? | ||||
| Scleritis | |||||
| Scleroderma | Suspected | IV? | Scl-70 Anti-topoisomerase | dysregulated apoptosis? | |
| Serum Sickness | III | ||||
| Sjögren's syndrome | Accepted | Anti-ro. Also, they are often present in Sjögren's syndrome. | |||
| Spondyloarthropathy | HLA-B27 | ||||
| Still's disease see Juvenile Rheumatoid Arthritis | ANA | macrophage migration inhibitory factor | |||
| Stiff person syndrome | Suspected | glutamic acid decarboxylase (GAD), | GLRA1 (glycine receptor | ||
| Subacute bacterial endocarditis (SBE) | III | essential mixed cryoglobulinemia | |||
| Susac's syndrome | |||||
| Sweet's syndrome | GCSF | ||||
| Sydenham chorea see PANDAS | |||||
| Sympathetic ophthalmia | ocular antigens following trauma | ||||
| Systemic lupus erythematosis see Lupus erythematosis | III | ||||
| Takayasu's arteritis | |||||
| Temporal arteritis (also known as "giant cell arteritis") | Accepted | IV | |||
| Thrombocytopenia | II | glycoproteins IIb-IIIa or Ib-IX in ITP anti-ADAMTS13 in TTP. and HUS anti-cardiolipin (anti-cardiolipin antibodies) and β2 glycoprotein I in Antiphospholipid syndrome anti-HPA-1a, anti-HPA-5b, and others in NAIT | multiple mechanisms | ||
| Tolosa-Hunt syndrome | |||||
| Transverse myelitis | Accepted | Transverse Myelitis is a rare neurological disorder that is part of a spectrum of neuroimmunologic diseases of the central nervous system. http://www.myelitis.org/ | |||
| Ulcerative colitis (one of two types of idiopathic inflammatory bowel disease "IBD") | Accepted | IV | |||
| Undifferentiated connective tissue disease different from Mixed connective tissue disease | Accepted | anti-nuclear antibody | HLA-DR4 | ||
| Undifferentiated spondyloarthropathy | |||||
| Urticarial vasculitis | II? | anti C1q antibodies | clinically may resemble type I hypersensitivity! | ||
| Vasculitis | Accepted | III | sometimes ANCA | ||
| Vitiligo | Suspected | NALP-1 RERE, PTPN22, LPP, IL2RA, GZMB, UBASH3A and C1QTNF6 | |||
| Wegener's granulomatosis | Accepted | Anti-neutrophil cytoplasmic(cANCA) |
Read more about this topic: Autoimmune Disease